메뉴 건너뛰기




Volumn 17, Issue 2, 2011, Pages 94-102

Targeting of metabotropic glutamate receptors for the treatment of schizophrenia

Author keywords

Antipsychotic; MGlu1 receptor; mGlu2 3 receptor; Schizophrenia

Indexed keywords

1 AMINO 1,5 INDANDICARBOXYLIC ACID; 2 AMINO 2 (2 CARBOXYCYCLOPROPYL) 3 (XANTHEN 9 YL)PROPIONIC ACID; 2 AMINO 3 (3,4 DICHLOROBENZYLOXY) 6 FLUOROBICYCLO[3.1.0]HEXANE 2,6 DICARBOXYLIC ACID; 2 CYCLOPROPYL 5 [1 (2 FLUORO 3 PYRIDINYL) 5 METHYL 1H 1,2,3 TRIAZOL 4 YL] 2,3 DIHYDRO 1H ISOINDOL 1 ONE; 3 ETHYL 2 METHYL QUINOLIN 6 YL (4 METHOXY CYCLOHEXYL)METHANONE METHANESULFONATE; 4 [1 (2 FLUOROPYRIDINE 3 YL) 5 METHYL 1H 1,2,3 TRIAZOL 4 YL]N ISOPROPYL N METHYL 3,6 DIHYDROPYRIDINE 1(2H)CARBOXAMIDE; 4 [2 AMINO 4 (METHYLTHIO)BUTYRYLAMINO] 2 THIABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID 2,2 DIOXIDE; 4 AMINO 2 OXABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; 4 AMINO 2 THIABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID 2,2 DIOXIDE; 4 CARBOXY 2 METHYLPHENYLGLYCINE; 9 DIMETHYLAMINO 3 (N HEXA METHYLENEIMINYL) 3H 5 THIA 1,3,6 TRIAZAFLUOREN ONE; A 841720; BAY 367620; CLOZAPINE; EGLUMETAD; LY 487379; METABOTROPIC RECEPTOR 1; METABOTROPIC RECEPTOR 1 ANTAGONIST; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR 2 AGONIST; METABOTROPIC RECEPTOR 2 POTENTIATOR; METABOTROPIC RECEPTOR 3; METABOTROPIC RECEPTOR 3 AGONIST; METABOTROPIC RECEPTOR AGONIST; METABOTROPIC RECEPTOR ANTAGONIST; MGS 0008; MGS 0028; OLANZAPINE; PLACEBO; UNCLASSIFIED DRUG;

EID: 79953311403     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161211795049570     Document Type: Article
Times cited : (34)

References (98)
  • 1
    • 0029082109 scopus 로고
    • Symptoms, signs, and diagnosis of schizophrenia
    • Andreasen NC. Symptoms, signs, and diagnosis of schizophrenia. Lancet 1995; 346: 477-81.
    • (1995) Lancet , vol.346 , pp. 477-481
    • Andreasen, N.C.1
  • 2
    • 39049174296 scopus 로고    scopus 로고
    • Cognitive impairment and functional outcome in schizophrenia and bipolar disorder
    • Green MF. Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. J Clin Psychiatry 2006; 67: e12.
    • (2006) J Clin Psychiatry , vol.67
    • Green, M.F.1
  • 3
    • 25144456112 scopus 로고    scopus 로고
    • Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
    • Lieberman JA, Stroup TS, McEvoy JP, et al. Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005; 353: 1209-23.
    • (2005) N Engl J Med , vol.353 , pp. 1209-1223
    • Lieberman, J.A.1    Stroup, T.S.2    McEvoy, J.P.3
  • 4
    • 0017255979 scopus 로고
    • Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs
    • Creese I, Burt DR, Snyder SH. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 1976; 192: 481-3.
    • (1976) Science , vol.192 , pp. 481-483
    • Creese, I.1    Burt, D.R.2    Snyder, S.H.3
  • 5
    • 0017068246 scopus 로고
    • Antipsychotic drug doses and neuroleptic/dopamine receptors
    • Seeman P, Lee T, Chau-Wong M, Wong K. Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 1976; 261: 717-9.
    • (1976) Nature , vol.261 , pp. 717-719
    • Seeman, P.1    Lee, T.2    Chau-Wong, M.3    Wong, K.4
  • 7
    • 0031979134 scopus 로고    scopus 로고
    • Schizophrenia and glutamate transmission
    • Tamminga CA. Schizophrenia and glutamate transmission. Crit Rev Neurobiol 1998; 12: 21-36.
    • (1998) Crit Rev Neurobiol , vol.12 , pp. 21-36
    • Tamminga, C.A.1
  • 8
    • 0030090430 scopus 로고    scopus 로고
    • Glutamate receptors and schizophrenia: Opportunities and caveats
    • Javitt DC. Glutamate receptors and schizophrenia: opportunities and caveats. Mol Psychiatry 1996; 1: 16-7.
    • (1996) Mol Psychiatry , vol.1 , pp. 16-17
    • Javitt, D.C.1
  • 9
    • 0019293020 scopus 로고
    • Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia
    • Kim JS, Kornhuber HH, Schmid-Burgk W, Holzmüller B. Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci Lett 1980; 20: 379-82.
    • (1980) Neurosci Lett , vol.20 , pp. 379-382
    • Kim, J.S.1    Kornhuber, H.H.2    Schmid-Burgk, W.3    Holzmüller, B.4
  • 11
    • 0025952455 scopus 로고
    • Recent advances in the phencyclidine model of schizophrenia
    • Javitt DC, Zukin SR. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry 1991; 148: 1301-8.
    • (1991) Am. J. Psychiatry , vol.148 , pp. 1301-1308
    • Javitt, D.C.1    Zukin, S.R.2
  • 12
    • 0029051676 scopus 로고
    • The phencyclidine-glutamate model of schizophrenia
    • Halberstadt AL. The phencyclidine-glutamate model of schizophrenia. Clin Neuropharmacol 1995; 18: 237-49.
    • (1995) Clin Neuropharmacol , vol.18 , pp. 237-249
    • Halberstadt, A.L.1
  • 13
    • 0030057542 scopus 로고    scopus 로고
    • The behavioral and neurochemical effects of phencyclidine in humans and animals: Some implications for modeling psychosis
    • Steinpreis PE. The behavioral and neurochemical effects of phencyclidine in humans and animals: Some implications for modeling psychosis. Behavioral Brain Res 1996; 74: 45-55.
    • (1996) Behavioral Brain Res , vol.74 , pp. 45-55
    • Steinpreis, P.E.1
  • 14
    • 0026437728 scopus 로고
    • Molecular diversity of glutamate receptors and implications for brain function
    • Nakanishi S. Molecular diversity of glutamate receptors and implications for brain function. Science 1992; 258: 597-603.
    • (1992) Science , vol.258 , pp. 597-603
    • Nakanishi, S.1
  • 15
    • 0028340001 scopus 로고
    • Molecular diversity and functions of glutamate receptors
    • Nakanishi S, Masu M. Molecular diversity and functions of glutamate receptors. Ann Rev Biophys Biomol Struct 1994; 23: 319-48.
    • (1994) Ann Rev Biophys Biomol Struct , vol.23 , pp. 319-348
    • Nakanishi, S.1    Masu, M.2
  • 16
    • 0026542513 scopus 로고
    • The metabotropic glutamate receptors: Structure and fuctions
    • Pin JP, Duvoisin R. The metabotropic glutamate receptors: structure and fuctions. J Neurochem 1992; 58: 1184-6.
    • (1992) J Neurochem , vol.58 , pp. 1184-1186
    • Pin, J.P.1    Duvoisin, R.2
  • 17
    • 0027395275 scopus 로고
    • Metabotropic glutamate receptors in brain function and pathology
    • Schoepp DD, Conn PJ. Metabotropic glutamate receptors in brain function and pathology. Trends Pharmacol Sci 1993; 14: 13-20.
    • (1993) Trends Pharmacol Sci , vol.14 , pp. 13-20
    • Schoepp, D.D.1    Conn, P.J.2
  • 18
    • 0030995878 scopus 로고    scopus 로고
    • Pharmacology and functions of metabotropic glutamate receptors
    • Conn PJ, Pin JP. Pharmacology and functions of metabotropic glutamate receptors. Ann Rev Pharmacol Toxicol 1997; 37: 205-37.
    • (1997) Ann Rev Pharmacol Toxicol , vol.37 , pp. 205-237
    • Conn, P.J.1    Pin, J.P.2
  • 19
    • 0027190384 scopus 로고
    • Distribution of the messenger RNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat
    • Ohishi H, Shigemoto R, Nakanishi S, Mizuno N. Distribution of the messenger RNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat. Neuroscience 1993; 53: 1009-18.
    • (1993) Neuroscience , vol.53 , pp. 1009-1018
    • Ohishi, H.1    Shigemoto, R.2    Nakanishi, S.3    Mizuno, N.4
  • 20
    • 0027410488 scopus 로고
    • Signal transduction, pharmacological properties, and expression patterns of two rat metabotropic glutamate receptors, mGluR3 and mGluR4
    • Tanabe Y, Nomura A, Masu M, et al. Signal transduction, pharmacological properties, and expression patterns of two rat metabotropic glutamate receptors, mGluR3 and mGluR4. J Neurosci 1993; 13: 1372-8.
    • (1993) J Neurosci , vol.13 , pp. 1372-1378
    • Tanabe, Y.1    Nomura, A.2    Masu, M.3
  • 21
    • 0030045889 scopus 로고    scopus 로고
    • Preand postsynaptic localization of a metabotropic glutamate receptor, mGluR2, in the rat brain: An immunohistochemical study with a monoclonal antibody
    • Neki A, Ohishi H, Kaneko T, Shigemoto R, Nakanishi S, Mizuno N. Preand postsynaptic localization of a metabotropic glutamate receptor, mGluR2, in the rat brain: an immunohistochemical study with a monoclonal antibody. Neurosci Lett 1996; 202: 197-200.
    • (1996) Neurosci Lett , vol.202 , pp. 197-200
    • Neki, A.1    Ohishi, H.2    Kaneko, T.3    Shigemoto, R.4    Nakanishi, S.5    Mizuno, N.6
  • 22
    • 67649981850 scopus 로고    scopus 로고
    • Differential expression of metabotropic glutamate receptors 2 and 3 in schizophrenia: A mechanism for antipsychotic drug action?
    • Ghose S, Gleason KA, Potts BW, Lewis-Amezcua K, Tamminga CA. Differential expression of metabotropic glutamate receptors 2 and 3 in schizophrenia: a mechanism for antipsychotic drug action? Am J Psychiatry 2009; 166: 812-20.
    • (2009) Am J Psychiatry , vol.166 , pp. 812-820
    • Ghose, S.1    Gleason, K.A.2    Potts, B.W.3    Lewis-Amezcua, K.4    Tamminga, C.A.5
  • 23
    • 40449139964 scopus 로고    scopus 로고
    • Identification of a serotonin/glutamate receptor complex implicated in psychosis
    • González-Maeso J, Ang RL, Yuen T, et al. Identification of a serotonin/glutamate receptor complex implicated in psychosis. Nature 2008; 452: 93-7.
    • (2008) Nature , vol.452 , pp. 93-97
    • González-Maeso, J.1    Ang, R.L.2    Yuen, T.3
  • 24
    • 9644291602 scopus 로고    scopus 로고
    • A case-control study of the relationship between the metabotropic glutamate receptor 3 gene and schizophrenia in the Chinese population
    • Chen Q, He G, Chen Q, et al. A case-control study of the relationship between the metabotropic glutamate receptor 3 gene and schizophrenia in the Chinese population. Schizophr Res 2005; 73: 21-6.
    • (2005) Schizophr Res , vol.73 , pp. 21-26
    • Chen, Q.1    He, G.2    Chen, Q.3
  • 25
    • 4344624909 scopus 로고    scopus 로고
    • Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia
    • Egan MF, Straub RE, Goldberg TE, et al. Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. Proc Natl Acad Sci USA 2004; 101: 12604-9.
    • (2004) Proc Natl Acad Sci USA , vol.101 , pp. 12604-12609
    • Egan, M.F.1    Straub, R.E.2    Goldberg, T.E.3
  • 26
    • 12444314603 scopus 로고    scopus 로고
    • Positive associations of polymorphisms in the metabotropic glutamate receptor type 3 gene (GRM3) with schizophrenia
    • Fujii Y, Shibata H, Kikuta R, et al. Positive associations of polymorphisms in the metabotropic glutamate receptor type 3 gene (GRM3) with schizophrenia. Psychiatr Genet 2003; 13: 71-6.
    • (2003) Psychiatr Genet , vol.13 , pp. 71-76
    • Fujii, Y.1    Shibata, H.2    Kikuta, R.3
  • 27
    • 45349086319 scopus 로고    scopus 로고
    • Expression of a GRM3 splice variant is increased in the dorsolateral prefrontal cortex of individuals carrying a schizophrenia risk SNP
    • Sartorius LJ, Weinberger DR, Hyde TM, Harrison PJ, Kleinman JE, Lipska BK. Expression of a GRM3 splice variant is increased in the dorsolateral prefrontal cortex of individuals carrying a schizophrenia risk SNP. Neuropsychopharmacology 2008; 33: 2626-34.
    • (2008) Neuropsychopharmacology , vol.33 , pp. 2626-2634
    • Sartorius, L.J.1    Weinberger, D.R.2    Hyde, T.M.3    Harrison, P.J.4    Kleinman, J.E.5    Lipska, B.K.6
  • 28
    • 0034649605 scopus 로고    scopus 로고
    • Synthesis, SARs, and pharmacological characterization of 2-amino-3 or 6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives as potent, selective, and orally active group II metabotropic glutamate receptor agonists
    • Nakazato A, Kumagai T, Sakagami K, et al. Synthesis, SARs, and pharmacological characterization of 2-amino-3 or 6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives as potent, selective, and orally active group II metabotropic glutamate receptor agonists. J Med Chem 2000; 43: 4893-909.
    • (2000) J Med Chem , vol.43 , pp. 4893-48909
    • Nakazato, A.1    Kumagai, T.2    Sakagami, K.3
  • 29
    • 0032575715 scopus 로고    scopus 로고
    • Reversal of phencyclidine effects by a group II metabotropic rceptor agonists in rats
    • Moghaddam B, Adams BW. Reversal of phencyclidine effects by a group II metabotropic rceptor agonists in rats. Science 1998; 281: 1349-52.
    • (1998) Science , vol.281 , pp. 1349-1352
    • Moghaddam, B.1    Adams, B.W.2
  • 30
    • 0034068655 scopus 로고    scopus 로고
    • Attenuation of specific PCPevoked behaviors by the potent mGluR2/3 receptor agonist, LY379268 and comparison with the atypical antipsychotic, clozapine
    • Cartmell J, Monn J, Schoepp DD. Attenuation of specific PCPevoked behaviors by the potent mGluR2/3 receptor agonist, LY379268 and comparison with the atypical antipsychotic, clozapine. Psychopharmacology 2000; 148: 423-9.
    • (2000) Psychopharmacology , vol.148 , pp. 423-429
    • Cartmell, J.1    Monn, J.2    Schoepp, D.D.3
  • 31
    • 27744597869 scopus 로고    scopus 로고
    • A selective allosteric potentiator of metabotropic glutamate (mGlu) 2 receptors has effects similar to an orthosteric mGlu2/3 receptor agonist in mouse models predictive of antipsychotic activity
    • Galici R, Echemendia NG, Rodriguez AL, Conn PJ. A selective allosteric potentiator of metabotropic glutamate (mGlu) 2 receptors has effects similar to an orthosteric mGlu2/3 receptor agonist in mouse models predictive of antipsychotic activity. J Pharmacol Exp Ther 2005; 315: 1181-7.
    • (2005) J Pharmacol Exp Ther , vol.315 , pp. 1181-1187
    • Galici, R.1    Echemendia, N.G.2    Rodriguez, A.L.3    Conn, P.J.4
  • 32
    • 34250162538 scopus 로고    scopus 로고
    • In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders
    • Rorick-Kehn LM, Johnson BG, Knitowski KM, et al. In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders. Psychopharmacology (Berl) 2007; 193: 121-36.
    • (2007) Psychopharmacology (Berl) , vol.193 , pp. 121-136
    • Rorick-Kehn, L.M.1    Johnson, B.G.2    Knitowski, K.M.3
  • 33
    • 0037769877 scopus 로고    scopus 로고
    • Antipsychotic action of selective group II metabotropic glutamate receptor agonist MGS0008 and MGS0028 on conditioned avoidance responses in the rat
    • Takamori K, Hirota S, Chaki S, Tanaka M. Antipsychotic action of selective group II metabotropic glutamate receptor agonist MGS0008 and MGS0028 on conditioned avoidance responses in the rat. Life Sci 2003; 73: 1721-8.
    • (2003) Life Sci , vol.73 , pp. 1721-1728
    • Takamori, K.1    Hirota, S.2    Chaki, S.3    Tanaka, M.4
  • 34
    • 45749139623 scopus 로고    scopus 로고
    • Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxyli c acid (LY404039)
    • Fell MJ, Svensson KA, Johnson BG, Schoepp DD. Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxyli c acid (LY404039). J Pharmacol Exp Ther 2008; 326: 209-17.
    • (2008) J Pharmacol Exp Ther , vol.326 , pp. 209-217
    • Fell, M.J.1    Svensson, K.A.2    Johnson, B.G.3    Schoepp, D.D.4
  • 35
    • 61449150536 scopus 로고    scopus 로고
    • Effects of a metabotropic glutamate receptor group II agonist LY354740 in animal models of positive schizophrenia symptoms and cognition
    • Schlumberger C, Schäfer D, Barberi C, et al. Effects of a metabotropic glutamate receptor group II agonist LY354740 in animal models of positive schizophrenia symptoms and cognition. Behav Pharmacol 2009; 20: 56-66.
    • (2009) Behav Pharmacol , vol.20 , pp. 56-66
    • Schlumberger, C.1    Schäfer, D.2    Barberi, C.3
  • 36
    • 1842664372 scopus 로고    scopus 로고
    • Pharmacological manipulation of mGlu2 receptors influences cognitive performance in the rodent
    • Higgins GA, Ballard TM, Kew JN, et al. Pharmacological manipulation of mGlu2 receptors influences cognitive performance in the rodent. Neuropharmacology 2004; 46: 907-17.
    • (2004) Neuropharmacology , vol.46 , pp. 907-917
    • Higgins, G.A.1    Ballard, T.M.2    Kew, J.N.3
  • 37
    • 35348856414 scopus 로고    scopus 로고
    • Blockade of the metabotropic glutamate 2/3 receptors enhances social memory via the AMPA receptor in rats
    • Shimazaki T, Kaku A, Chaki S. Blockade of the metabotropic glutamate 2/3 receptors enhances social memory via the AMPA receptor in rats. Eur J Pharmacol 2007; 575: 94-7.
    • (2007) Eur J Pharmacol , vol.575 , pp. 94-97
    • Shimazaki, T.1    Kaku, A.2    Chaki, S.3
  • 38
    • 34249888474 scopus 로고    scopus 로고
    • Stimulation of the metabotropic glutamate 2/3 receptor attenuates social novelty discrimination deficits induced by neonatal phencyclidine treatment
    • Harich S, Gross G, Bespalov A. Stimulation of the metabotropic glutamate 2/3 receptor attenuates social novelty discrimination deficits induced by neonatal phencyclidine treatment. Psychopharmacology (Berl) 2007; 192: 511-9.
    • (2007) Psychopharmacology (Berl) , vol.192 , pp. 511-519
    • Harich, S.1    Gross, G.2    Bespalov, A.3
  • 39
    • 79952283187 scopus 로고    scopus 로고
    • The mGluR2/3 agonist LY379268 reverses post-weaning social isolation-induced recognition memory deficits in the rat
    • [Epub ahead of print]
    • Jones CA, Brown AM, Auer DP, Fone KC. The mGluR2/3 agonist LY379268 reverses post-weaning social isolation-induced recognition memory deficits in the rat. Psychopharmacology (Berl) 2010; [Epub ahead of print].
    • (2010) Psychopharmacology (Berl)
    • Jones, C.A.1    Brown, A.M.2    Auer, D.P.3    Fone, K.C.4
  • 40
    • 77952889358 scopus 로고    scopus 로고
    • Selective potentiation of the metabotropic glutamate receptor subtype 2 blocks phencyclidine-induced hyperlocomotion and brain activation
    • Hackler EA, Byun NE, Jones CK, et al. Selective potentiation of the metabotropic glutamate receptor subtype 2 blocks phencyclidine-induced hyperlocomotion and brain activation. Neuroscience 2010; 168: 209-18.
    • (2010) Neuroscience , vol.168 , pp. 209-218
    • Hackler, E.A.1    Byun, N.E.2    Jones, C.K.3
  • 41
    • 78649589979 scopus 로고    scopus 로고
    • Effects of a positive allosteric modulator of mGlu2 receptors LY487379 on cognitive flexibility and impulsive-like responding in rats
    • Nikiforuk A, Popik P, Drescher KU, et al. Effects of a positive allosteric modulator of mGlu2 receptors LY487379 on cognitive flexibility and impulsive-like responding in rats. J Pharmacol Exp Ther 2010; 335: 665-73.
    • (2010) J Pharmacol Exp Ther , vol.335 , pp. 665-673
    • Nikiforuk, A.1    Popik, P.2    Drescher, K.U.3
  • 42
    • 33746772807 scopus 로고    scopus 로고
    • Subchronic administration of LY354740 does not modify ketamine-evoked behavior and neuronal activity in rats
    • Imre G, Fokkema DS, Ter Horst GJ. Subchronic administration of LY354740 does not modify ketamine-evoked behavior and neuronal activity in rats. Eur J Pharmacol 2006; 544: 77-81.
    • (2006) Eur J Pharmacol , vol.544 , pp. 77-81
    • Imre, G.1    Fokkema, D.S.2    Ter Horst, G.J.3
  • 43
    • 34948858402 scopus 로고    scopus 로고
    • Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: A randomized Phase 2 clinical trial
    • Patil ST, Zhang L, Martenyi F, et al. Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial. Nat Med 2007; 13: 1102-7.
    • (2007) Nat Med , vol.13 , pp. 1102-1107
    • Patil, S.T.1    Zhang, L.2    Martenyi, F.3
  • 44
    • 20944439080 scopus 로고    scopus 로고
    • Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects
    • Krystal JH, Abi-Saab W, Perry E, et al. Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects. Psychopharmacology (Berl) 2005; 179: 303-9.
    • (2005) Psychopharmacology (Berl) , vol.179 , pp. 303-309
    • Krystal, J.H.1    Abi-Saab, W.2    Perry, E.3
  • 45
    • 0037475156 scopus 로고    scopus 로고
    • Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: Modulation by a group II selective metabotropic glutamate receptor agonist LY379268
    • Lorrain DS, Baccei CS, Bristow LJ, Anderson JJ, Varney MA. Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268. Neuroscience 2003; 117: 697-706.
    • (2003) Neuroscience , vol.117 , pp. 697-706
    • Lorrain, D.S.1    Baccei, C.S.2    Bristow, L.J.3    Anderson, J.J.4    Varney, M.A.5
  • 46
    • 57649121946 scopus 로고    scopus 로고
    • Endogenous serotonin and serotonin2C receptors are involved in the ability of M100907 to suppress cortical glutamate release induced by NMDA receptor blockade
    • Calcagno E, Carli M, Baviera M, Invernizzi RW. Endogenous serotonin and serotonin2C receptors are involved in the ability of M100907 to suppress cortical glutamate release induced by NMDA receptor blockade. J Neurochem 2009; 108: 521-32.
    • (2009) J Neurochem , vol.108 , pp. 521-532
    • Calcagno, E.1    Carli, M.2    Baviera, M.3    Invernizzi, R.W.4
  • 47
    • 33749645423 scopus 로고    scopus 로고
    • Cognitive dysfunction in schizophrenia: Convergence of gamma-aminobutyric acid and glutamate alterations
    • Lewis DA, Moghaddam B. Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations. Arch Neurol 2006; 63: 1372-6.
    • (2006) Arch Neurol , vol.63 , pp. 1372-1376
    • Lewis, D.A.1    Moghaddam, B.2
  • 48
    • 58149119377 scopus 로고    scopus 로고
    • Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia
    • Conn PJ, Lindsley CW, Jones CK. Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia. Trends Pharmacol Sci 2009; 30: 25-31.
    • (2009) Trends Pharmacol Sci , vol.30 , pp. 25-31
    • Conn, P.J.1    Lindsley, C.W.2    Jones, C.K.3
  • 49
    • 43649089662 scopus 로고    scopus 로고
    • Differential effects of antipsychotic and glutamatergic agents on the phMRI response to phencyclidine
    • Gozzi A, Large CH, Schwarz A, Bertani S, Crestan V, Bifone A. Differential effects of antipsychotic and glutamatergic agents on the phMRI response to phencyclidine. Neuropsychopharmacology 2008; 33: 1690-703.
    • (2008) Neuropsychopharmacology , vol.33 , pp. 1690-1703
    • Gozzi, A.1    Large, C.H.2    Schwarz, A.3    Bertani, S.4    Crestan, V.5    Bifone, A.6
  • 50
    • 2542443473 scopus 로고    scopus 로고
    • Selective action of (-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268), a group II metabotropic glutamate receptor agonist, on basal and phencyclidine-induced dopamine release in the nucleus accumbens shell
    • Greenslade RG, Mitchell SN. Selective action of (-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268), a group II metabotropic glutamate receptor agonist, on basal and phencyclidine-induced dopamine release in the nucleus accumbens shell. Neuropharmacology 2004; 47: 1-8.
    • (2004) Neuropharmacology , vol.47 , pp. 1-8
    • Greenslade, R.G.1    Mitchell, S.N.2
  • 51
    • 29244474593 scopus 로고    scopus 로고
    • Metabotropic glutamate 2/3 receptor antagonist, MGS0039, increases extracellular dopamine levels in the nucleus accumbens shell
    • Karasawa J, Yoshimizu T, Chaki S. A metabotropic glutamate 2/3 receptor antagonist, MGS0039, increases extracellular dopamine levels in the nucleus accumbens shell. Neurosci Lett 2006; 393: 127-30.
    • (2006) Neurosci Lett , vol.393 , pp. 127-130
    • Karasawa, J.1    Yoshimizu, T.2    Chaki, S.A.3
  • 52
    • 0034992871 scopus 로고    scopus 로고
    • Acute increases in monoamine release in the rat prefrontal cortex by the mGlu2/3 agonist LY379268 are similar in profile to risperidone, not locally mediated, and can be elicited in the presence of uptake blockade
    • Cartmell J, Perry KW, Salhoff CR, Monn JA, Schoepp DD. Acute increases in monoamine release in the rat prefrontal cortex by the mGlu2/3 agonist LY379268 are similar in profile to risperidone, not locally mediated, and can be elicited in the presence of uptake blockade. Neuropharmacology 2001; 40: 847-55.
    • (2001) Neuropharmacology , vol.40 , pp. 847-855
    • Cartmell, J.1    Perry, K.W.2    Salhoff, C.R.3    Monn, J.A.4    Schoepp, D.D.5
  • 53
    • 0033981186 scopus 로고    scopus 로고
    • Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex
    • Marek GJ, Wright RA, Schoepp DD, Monn JA, Aghajanian GK. Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex. J Pharmacol Exp Ther 2000; 292: 76-87.
    • (2000) J Pharmacol Exp Ther , vol.292 , pp. 76-87
    • Marek, G.J.1    Wright, R.A.2    Schoepp, D.D.3    Monn, J.A.4    Aghajanian, G.K.5
  • 54
    • 0033797463 scopus 로고    scopus 로고
    • Behavioral evidence for interactions between a hallucinogenic drug and group II metabotropic glutamate receptors
    • Gewirtz JC, Marek GJ. Behavioral evidence for interactions between a hallucinogenic drug and group II metabotropic glutamate receptors. Neuropsychopharmacology 2000; 23: 569-76.
    • (2000) Neuropsychopharmacology , vol.23 , pp. 569-576
    • Gewirtz, J.C.1    Marek, G.J.2
  • 55
    • 34547198448 scopus 로고    scopus 로고
    • A selective positive allosteric modulator of metabotropic glutamate receptor subtype 2 blocks a hallucinogenic drug model of psychosis
    • Benneyworth MA, Xiang Z, Smith RL, Garcia EE, Conn PJ, Sanders-Bush E. A selective positive allosteric modulator of metabotropic glutamate receptor subtype 2 blocks a hallucinogenic drug model of psychosis. Mol Pharmacol 2007; 72: 477-84.
    • (2007) Mol Pharmacol , vol.72 , pp. 477-484
    • Benneyworth, M.A.1    Xiang, Z.2    Smith, R.L.3    Garcia, E.E.4    Conn, P.J.5    Sanders-Bush, E.6
  • 56
    • 0038810014 scopus 로고    scopus 로고
    • Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: Opposite regulation of glutamate transporter proteins
    • Aronica E, Gorter JA, Ijlst-Keizers H, et al. Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: opposite regulation of glutamate transporter proteins. Eur J Neurosci 2003; 17: 2106-18.
    • (2003) Eur J Neurosci , vol.17 , pp. 2106-2118
    • Aronica, E.1    Gorter, J.A.2    Ijlst-Keizers, H.3
  • 57
    • 0032403407 scopus 로고    scopus 로고
    • Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-beta
    • Bruno V, Battaglia G, Casabona G, Copani A, Caciagli F, Nicoletti F. Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-beta. J Neurosci 1998; 18: 9594-600.
    • (1998) J Neurosci , vol.18 , pp. 9594-9600
    • Bruno, V.1    Battaglia, G.2    Casabona, G.3    Copani, A.4    Caciagli, F.5    Nicoletti, F.6
  • 58
    • 0033943840 scopus 로고    scopus 로고
    • N-Acetylaspartylglutamate: The most abundant peptide neurotransmitter in the mammalian central nervous system
    • Neale JH, Bzdega T, Wroblewska B. N-Acetylaspartylglutamate: the most abundant peptide neurotransmitter in the mammalian central nervous system. J Neurochem 2000; 75: 443-52.
    • (2000) J Neurochem , vol.75 , pp. 443-452
    • Neale, J.H.1    Bzdega, T.2    Wroblewska, B.3
  • 59
    • 36849039063 scopus 로고    scopus 로고
    • Phencyclidine and dizocilpine induced behaviors reduced by Nacetylaspartylglutamate peptidase inhibition via metabotropic glutamate receptors
    • Olszewski RT, Wegorzewska MM, Monteiro AC, et al. Phencyclidine and dizocilpine induced behaviors reduced by Nacetylaspartylglutamate peptidase inhibition via metabotropic glutamate receptors. Biol Psychiatry 2008; 63: 86-91.
    • (2008) Biol Psychiatry , vol.63 , pp. 86-91
    • Olszewski, R.T.1    Wegorzewska, M.M.2    Monteiro, A.C.3
  • 60
    • 67349089876 scopus 로고    scopus 로고
    • Effects of Nacetylaspartylglutamate (NAAG) at group II mGluRs and NMDAR
    • Fricker AC, Mok MH, de la Flor R, et al. Effects of Nacetylaspartylglutamate (NAAG) at group II mGluRs and NMDAR. Neuropharmacology 2009; 56: 1060-7.
    • (2009) Neuropharmacology , vol.56 , pp. 1060-1067
    • Fricker, A.C.1    Mok, M.H.2    de la Flor, R.3
  • 61
    • 0029187946 scopus 로고
    • The metabotropic glutamate receptors: Structure and functions
    • Pin JP, Duvoisin R. The metabotropic glutamate receptors: structure and functions. Neuropharmacology 1995; 34: 1-26.
    • (1995) Neuropharmacology , vol.34 , pp. 1-26
    • Pin, J.P.1    Duvoisin, R.2
  • 62
    • 0026716350 scopus 로고
    • Distribution of the Mrna for a metabotropic glutamate receptor (mGluR1) in the central nervous system: An in situ hybridization study in adult and developing rat
    • Shigemoto R, Nakanishi S, Mizuno N. Distribution of the Mrna for a metabotropic glutamate receptor (mGluR1) in the central nervous system: an in situ hybridization study in adult and developing rat. J Comp Neurol 1992; 322: 121-35.
    • (1992) J Comp Neurol , vol.322 , pp. 121-135
    • Shigemoto, R.1    Nakanishi, S.2    Mizuno, N.3
  • 63
    • 0026794813 scopus 로고
    • Cellular localization of a metabotropic glutamate receptor in rat brain
    • Martin LJ, Blackstone CD, Huganir RL, Price DL. Cellular localization of a metabotropic glutamate receptor in rat brain. Neuron 1992; 9: 259-70.
    • (1992) Neuron , vol.9 , pp. 259-270
    • Martin, L.J.1    Blackstone, C.D.2    Huganir, R.L.3    Price, D.L.4
  • 65
    • 0034053573 scopus 로고    scopus 로고
    • Evidence for a compromised dorsolateral prefrontal cortical parallel circuit in schizophrenia
    • Bunney WE, Bunney BG. Evidence for a compromised dorsolateral prefrontal cortical parallel circuit in schizophrenia. Brain Res Brain Res Rev 2000; 31: 138-46.
    • (2000) Brain Res Brain Res Rev , vol.31 , pp. 138-146
    • Bunney, W.E.1    Bunney, B.G.2
  • 68
    • 71749085915 scopus 로고    scopus 로고
    • Association and linkage analyses of RGS4 polymorphisms in schizophrenia
    • Chowdari KV, Mirnics K, Semwal P, et al. Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum Mol Genet 2002; 11: 1373-80.
    • (2002) Hum Mol Genet , vol.11 , pp. 1373-1380
    • Chowdari, K.V.1    Mirnics, K.2    Semwal, P.3
  • 70
    • 78649743311 scopus 로고    scopus 로고
    • Alterations in metabotropic glutamate receptor 1{alpha} and regulator of G protein signaling 4 in the prefrontal cortex in schizophrenia
    • Volk DW, Eggan SM, Lewis DA. Alterations in metabotropic glutamate receptor 1{alpha} and regulator of G protein signaling 4 in the prefrontal cortex in schizophrenia. Am J Psychiatry 2010; 167: 1489-98.
    • (2010) Am J Psychiatry , vol.167 , pp. 1489-1498
    • Volk, D.W.1    Eggan, S.M.2    Lewis, D.A.3
  • 71
    • 0035812645 scopus 로고    scopus 로고
    • Neuroprotective and behavioral effects of the selective metabotropic glutamate mGlu1 receptor antagonist BAY 36-7620
    • De Vry J, Horváth E, Schreiber R. Neuroprotective and behavioral effects of the selective metabotropic glutamate mGlu1 receptor antagonist BAY 36-7620. Eur J Pharmacol 2001; 428: 203-14.
    • (2001) Eur J Pharmacol , vol.428 , pp. 203-214
    • de Vry, J.1    Horváth, E.2    Schreiber, R.3
  • 72
    • 48049095987 scopus 로고    scopus 로고
    • Pharmacological effects of the metabotropic glutamate receptor 1 antagonist compared with those of the metabotropic glutamate receptor 5 antagonist and metabotropic glutamate receptor 2/3 agonist in rodents: Detailed investigations with a selective allosteric metabotropic glutamate receptor 1 antagonist
    • Satow A, Maehara S, Ise S, et al. Pharmacological effects of the metabotropic glutamate receptor 1 antagonist compared with those of the metabotropic glutamate receptor 5 antagonist and metabotropic glutamate receptor 2/3 agonist in rodents: detailed investigations with a selective allosteric metabotropic glutamate receptor 1 antagonist, FTIDC [4-[1-(2-fluoropyridine-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-nisopropyl -N-methyl-3,6-dihydropyridine-1(2H)-carboxamide]. J Pharmacol Exp Ther 2008; 326: 577-86.
    • (2008) J Pharmacol Exp Ther , vol.326 , pp. 577-586
    • Satow, A.1    Maehara, S.2    Ise, S.3
  • 73
    • 67649993985 scopus 로고    scopus 로고
    • Unique antipsychotic activities of the selective metabotropic glutamate receptor 1 allosteric antagonist 2-cyclopropyl-5-[1-(2-fluoro-3-pyridinyl)-5-methyl-1H-1, 2, 3,-triazole-4-yl]-2, 3-dihydro-1H-isoindol-1-one
    • Satow A, Suzuki G, Maehara S, et al. Unique antipsychotic activities of the selective metabotropic glutamate receptor 1 allosteric antagonist 2-cyclopropyl-5-[1-(2-fluoro-3-pyridinyl)-5-methyl-1H-1, 2, 3,-triazole-4-yl]-2, 3-dihydro-1H-isoindol-1-one. J Pharmacol Exp Ther 2009; 330: 179-90.
    • (2009) J Pharmacol Exp Ther , vol.330 , pp. 179-190
    • Satow, A.1    Suzuki, G.2    Maehara, S.3
  • 74
    • 77953622543 scopus 로고    scopus 로고
    • Pharmacological effects of metabotropic glutamate receptor ligands on prepulse inhibition in DBA/2J mice
    • Hikichi H, Nishino M, Fukushima M, et al. Pharmacological effects of metabotropic glutamate receptor ligands on prepulse inhibition in DBA/2J mice. Eur J Pharmacol 2010; 639: 99-105.
    • (2010) Eur J Pharmacol , vol.639 , pp. 99-105
    • Hikichi, H.1    Nishino, M.2    Fukushima, M.3
  • 75
    • 0347419233 scopus 로고    scopus 로고
    • Disruption of prepulse inhibition in mice lacking mGluR1
    • Brody SA, Conquet F, Geyer MA. Disruption of prepulse inhibition in mice lacking mGluR1. Eur J Neurosci 2003; 18: 3361-6.
    • (2003) Eur J Neurosci , vol.18 , pp. 3361-3366
    • Brody, S.A.1    Conquet, F.2    Geyer, M.A.3
  • 76
    • 0035817763 scopus 로고    scopus 로고
    • Augmented motor activity and reduced striatal preprodynorphin mRNA induction in response to acute amphetamine administration in metabotropic glutamate receptor 1 knockout mice
    • Mao L, Conquet F, Wang JQ. Augmented motor activity and reduced striatal preprodynorphin mRNA induction in response to acute amphetamine administration in metabotropic glutamate receptor 1 knockout mice. Neuroscience 2001; 106: 303-12.
    • (2001) Neuroscience , vol.106 , pp. 303-312
    • Mao, L.1    Conquet, F.2    Wang, J.Q.3
  • 77
    • 0028149789 scopus 로고
    • Deficient cerebellar long-term depression and impaired motor learning in mGluR1 mutant mice
    • Aiba A, Kano M, Chen C, et al. Deficient cerebellar long-term depression and impaired motor learning in mGluR1 mutant mice. Cell 1994; 79: 377-88.
    • (1994) Cell , vol.79 , pp. 377-388
    • Aiba, A.1    Kano, M.2    Chen, C.3
  • 78
    • 0027997686 scopus 로고
    • Motor deficit and impairment of synaptic plasticity in mice lacking mGluR1
    • Conquet F, Bashir ZI, Davies CH, et al. Motor deficit and impairment of synaptic plasticity in mice lacking mGluR1. Nature 1994; 372: 237-43.
    • (1994) Nature , vol.372 , pp. 237-243
    • Conquet, F.1    Bashir, Z.I.2    Davies, C.H.3
  • 79
    • 0032929398 scopus 로고    scopus 로고
    • Intracerebral administration of metabotropic glutamate receptor agonists disrupts prepulse inhibition of acoustic startle in Sprague-Dawley rats
    • Grauer SM, Marquis KL. Intracerebral administration of metabotropic glutamate receptor agonists disrupts prepulse inhibition of acoustic startle in Sprague-Dawley rats. Psychopharmacology 1999; 141: 405-12.
    • (1999) Psychopharmacology , vol.141 , pp. 405-412
    • Grauer, S.M.1    Marquis, K.L.2
  • 80
    • 21344470129 scopus 로고    scopus 로고
    • MGluR5, but not mGluR1, antagonist modifies MK-801-induced locomotor activity and deficit of prepulse inhibition
    • Pietraszek M, Gravius A, Schäfer D, Weil T, Trifanova D, Danysz W. mGluR5, but not mGluR1, antagonist modifies MK-801-induced locomotor activity and deficit of prepulse inhibition. Neuropharmacology 2005; 49: 73-85.
    • (2005) Neuropharmacology , vol.49 , pp. 73-85
    • Pietraszek, M.1    Gravius, A.2    Schäfer, D.3    Weil, T.4    Trifanova, D.5    Danysz, W.6
  • 81
    • 33750989894 scopus 로고    scopus 로고
    • Blockade of mGluR1 receptor results in analgesia and disruption of motor and cognitive performances: Effects of A-841720, a novel non-competitive mGluR1 receptor antagonist
    • El-Kouhen O, Lehto SG, Pan JB, et al. Blockade of mGluR1 receptor results in analgesia and disruption of motor and cognitive performances: effects of A-841720, a novel non-competitive mGluR1 receptor antagonist. Br J Pharmacol 2006; 149: 761-74.
    • (2006) Br J Pharmacol , vol.149 , pp. 761-774
    • El-Kouhen, O.1    Lehto, S.G.2    Pan, J.B.3
  • 82
    • 55949121550 scopus 로고    scopus 로고
    • The potent noncompetitive mGlu1 receptor antagonist BAY 36-7620 differentially affects synaptic plasticity in area cornu ammonis 1 of rat hippocampal slices and impairs acquisition in the water maze task in mice
    • Schröder UH, Müller T, Schreiber R, et al. The potent noncompetitive mGlu1 receptor antagonist BAY 36-7620 differentially affects synaptic plasticity in area cornu ammonis 1 of rat hippocampal slices and impairs acquisition in the water maze task in mice. Neuroscience 2008; 157: 385-95.
    • (2008) Neuroscience , vol.157 , pp. 385-395
    • Schröder, U.H.1    Müller, T.2    Schreiber, R.3
  • 83
    • 0037112011 scopus 로고    scopus 로고
    • Two distinct signaling pathways upregulate NMDA receptor responses via two distinct metabotropic glutamate receptor subtypes
    • Benquet P, Gee CE, Gerber U. Two distinct signaling pathways upregulate NMDA receptor responses via two distinct metabotropic glutamate receptor subtypes. J Neurosci 2002; 22: 9679-86.
    • (2002) J Neurosci , vol.22 , pp. 9679-9686
    • Benquet, P.1    Gee, C.E.2    Gerber, U.3
  • 84
    • 0036662898 scopus 로고    scopus 로고
    • Metabotropic glutamate receptor 1-induced upregulation of NMDA receptor current: Mediation through the Pyk2/Src-family kinase pathway in cortical neurons
    • Heidinger V, Manzerra P, Wang XQ, et al. Metabotropic glutamate receptor 1-induced upregulation of NMDA receptor current: mediation through the Pyk2/Src-family kinase pathway in cortical neurons. J Neurosci 2002; 22: 5452-61.
    • (2002) J Neurosci , vol.22 , pp. 5452-5461
    • Heidinger, V.1    Manzerra, P.2    Wang, X.Q.3
  • 85
    • 23044482517 scopus 로고    scopus 로고
    • Regulation of extracellular glutamate in the prefrontal cortex: Focus on the cystine glutamate exchanger and group I metabotropic glutamate receptors
    • Melendez RI, Vuthiganon J, Kalivas PW. Regulation of extracellular glutamate in the prefrontal cortex: focus on the cystine glutamate exchanger and group I metabotropic glutamate receptors. J Pharmacol Exp Ther 2005; 314: 139-47.
    • (2005) J Pharmacol Exp Ther , vol.314 , pp. 139-147
    • Melendez, R.I.1    Vuthiganon, J.2    Kalivas, P.W.3
  • 86
    • 65249107131 scopus 로고    scopus 로고
    • Schizophrenia from a neural circuitry perspective: Advancing toward rational pharmacological therapies
    • Lewis DA, Sweet RA. Schizophrenia from a neural circuitry perspective: advancing toward rational pharmacological therapies. J Clin Invest 2009; 119: 706-16.
    • (2009) J Clin Invest , vol.119 , pp. 706-716
    • Lewis, D.A.1    Sweet, R.A.2
  • 87
    • 2442691616 scopus 로고    scopus 로고
    • Group I metabotropic glutamate receptors inhibit GABA release at interneuron-Purkinje cell synapses through endocannabinoid production
    • Galante M, Diana MA. Group I metabotropic glutamate receptors inhibit GABA release at interneuron-Purkinje cell synapses through endocannabinoid production. J Neurosci 2004; 24: 4865-74.
    • (2004) J Neurosci , vol.24 , pp. 4865-4874
    • Galante, M.1    Diana, M.A.2
  • 88
    • 0035899382 scopus 로고    scopus 로고
    • Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors
    • Maejima T, Hashimoto K, Yoshida T, Aiba A, Kano M. Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors. Neuron 2001; 31: 463-475.
    • (2001) Neuron , vol.31 , pp. 463-475
    • Maejima, T.1    Hashimoto, K.2    Yoshida, T.3    Aiba, A.4    Kano, M.5
  • 89
    • 0035893233 scopus 로고    scopus 로고
    • Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus
    • Varma N, Carlson GC, Ledent C, Alger BE. Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus. J Neurosci 2001; 21: RC188.
    • (2001) J Neurosci , vol.21
    • Varma, N.1    Carlson, G.C.2    Ledent, C.3    Alger, B.E.4
  • 91
    • 0345016983 scopus 로고    scopus 로고
    • Distribution of mGluR1alpha and mGluR5 immunolabeling in primate prefrontal cortex
    • Muly EC, Maddox M, Smith Y. Distribution of mGluR1alpha and mGluR5 immunolabeling in primate prefrontal cortex. J Comp Neurol 2003; 467: 521-35.
    • (2003) J Comp Neurol , vol.467 , pp. 521-535
    • Muly, E.C.1    Maddox, M.2    Smith, Y.3
  • 92
    • 66249145103 scopus 로고    scopus 로고
    • Mapping the regulator of G protein signaling 4 (RGS4): Presynaptic and postsynaptic substrates for neuroregulation in prefrontal cortex
    • Paspalas CD, Selemon LD, Arnsten AF. Mapping the regulator of G protein signaling 4 (RGS4): presynaptic and postsynaptic substrates for neuroregulation in prefrontal cortex. Cereb Cortex 2009; 19: 2145-55.
    • (2009) Cereb Cortex , vol.19 , pp. 2145-2155
    • Paspalas, C.D.1    Selemon, L.D.2    Arnsten, A.F.3
  • 93
    • 0036091128 scopus 로고    scopus 로고
    • Differential distribution of group I and metabotropic glutamate receptors during rat cortical development
    • López-Bendito G, Shigemoto R, Fairén A, Luján R. Differential distribution of group I and metabotropic glutamate receptors during rat cortical development. Cereb Cortex 2002; 12: 625-38.
    • (2002) Cereb Cortex , vol.12 , pp. 625-638
    • López-Bendito, G.1    Shigemoto, R.2    Fairén, A.3    Luján, R.4
  • 94
    • 0027520283 scopus 로고
    • The metabotropic glutamate receptor (mGluR1alpha) is concentrated at perisynaptic membrane of neuronal subpopulations as detected by immunogold reaction
    • Baude A, Nusser Z, Roberts JD, Mulvihill E, McIlhinney RA, Somogyi P. The metabotropic glutamate receptor (mGluR1alpha) is concentrated at perisynaptic membrane of neuronal subpopulations as detected by immunogold reaction. Neuron 1993; 11: 771-87.
    • (1993) Neuron , vol.11 , pp. 771-787
    • Baude, A.1    Nusser, Z.2    Roberts, J.D.3    Mulvihill, E.4    McIlhinney, R.A.5    Somogyi, P.6
  • 95
    • 33947415606 scopus 로고    scopus 로고
    • Pharmacological and pharmacokinetic properties of a structurally novel, potent, and selective metabotropic glutamate 2/3 receptor agonist: In vitro characterization of agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]-hexane-4,6-dicarboxyl ic acid (LY404039)
    • Rorick-Kehn LM, Johnson BG, Burkey JL, et al. Pharmacological and pharmacokinetic properties of a structurally novel, potent, and selective metabotropic glutamate 2/3 receptor agonist: in vitro characterization of agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]-hexane-4,6-dicarboxyl ic acid (LY404039). J Pharmacol Exp Ther 2007; 321: 308-17.
    • (2007) J Pharmacol Exp Ther , vol.321 , pp. 308-317
    • Rorick-Kehn, L.M.1    Johnson, B.G.2    Burkey, J.L.3
  • 96
    • 0033602516 scopus 로고    scopus 로고
    • Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): Identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors
    • Monn JA, Valli MJ, Massey SM, et al. Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors. J Med Chem 1999; 42: 1027-40.
    • (1999) J Med Chem , vol.42 , pp. 1027-1040
    • Monn, J.A.1    Valli, M.J.2    Massey, S.M.3
  • 97
    • 0032848507 scopus 로고    scopus 로고
    • The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats
    • Cartmell J, Monn JA, Schoepp DD. The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats. J Pharmacol Exp Ther 1999; 291: 161-70.
    • (1999) J Pharmacol Exp Ther , vol.291 , pp. 161-170
    • Cartmell, J.1    Monn, J.A.2    Schoepp, D.D.3
  • 98
    • 34248667888 scopus 로고    scopus 로고
    • Pharmacological characterization of a new, orally active and potent allosteric metabotropic glutamate receptor 1 antagonist, 4-[1-(2-fluoropyridin-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl- N-methyl-3,6-dihydropyridine-1(2H)-carboxamide (FTIDC)
    • Suzuki G, Kimura T, Satow A, et al. Pharmacological characterization of a new, orally active and potent allosteric metabotropic glutamate receptor 1 antagonist, 4-[1-(2-fluoropyridin-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl- N-methyl-3,6-dihydropyridine-1(2H)-carboxamide (FTIDC). J Pharmacol Exp Ther 2008; 321: 1144-53.
    • (2008) J Pharmacol Exp Ther , vol.321 , pp. 1144-1153
    • Suzuki, G.1    Kimura, T.2    Satow, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.